文献速递头颈外科小儿耳鼻咽喉

老年评估缺陷与头颈癌治疗后健康相关生活质量下降的关联

Association of Deficits Identified by Geriatric Assessment With Deterioration of Health-Related Quality of Life in Patients Treated for Head and Neck Cancer.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2021-01-01

这项前瞻性队列研究纳入283例头颈癌患者,基线进行老年评估,随访2年。结果显示严重共病、IADL受限等老年缺陷与治疗后3个月及随访期间GHS/QOL下降显著相关,缺陷累积是主要因素。老年评估可能有助于决策和干预以减少生活质量损失。

要点

  • 严重共病、营养不良风险、IADL受限与治疗后3个月GHS/QOL下降相关。
  • 随访期间严重共病、IADL受限、活动受限、抑郁征象及居住方式与GHS/QOL进一步下降相关。
  • 老年缺陷累积是GHS/QOL下降的主要显著因素。

核心结论

  • 老年缺陷与头颈癌治疗后健康相关生活质量下降显著相关。
  • 老年评估可能有助于决策、指导干预并减少生活质量损失。

研究设计与样本

  • 前瞻性队列研究,纳入2014年10月至2016年5月一家三级转诊中心的369例头颈癌患者,基线进行老年评估,283例符合分析条件,随访2年时189例仍在研究中。
  • 分析在2020年3月至11月进行。

主要发现

  • 283例可分析患者平均(SD)年龄68.3(10.9)岁,193例(68.2%)为男性。
  • 治疗后3个月GHS/QOL下降与严重共病(β=-7.00,95%CI -12.43至1.56)、营养不良风险(β=-6.18,95%CI -11.55至-0.81)、IADL受限(β=-10.48,95%CI -16.39至-4.57)相关。
  • 随访期间GHS/QOL进一步下降与严重共病(β=-4.90,95%CI -9.70至-0.10)、IADL受限(β=-5.36,95%CI -10.50至-0.22)、活动受限(β=-6.78,95%CI -12.81至-0.75)、抑郁征象(β=-7.08,95%CI -13.10至-1.06)、需协助居住或养老院居住(β=-8.74,95%CI -15.75至-1.73)相关。
  • 老年缺陷累积是治疗后3个月GHS/QOL下降(每缺陷领域β=-3.17,95%CI -5.04至-1.30)和随访期间恶化(每领域每年β=-2.74,95%CI -4.28至-1.20)的主要显著因素。

关键数值与推荐

  • 老年评估包括成人共病评估27、多重用药、营养不良通用筛查工具、日常生活活动能力、工具性日常生活活动能力(IADL)、计时起立行走测试、简易精神状态检查、15项老年抑郁量表、婚姻状况和居住情况。
  • 主要结局指标为欧洲癌症研究与治疗组织生活质量问卷核心30的总体健康状况/生活质量(GHS/QOL)量表。

临床怎么用

  • 对头颈癌患者进行老年评估,识别严重共病、营养不良风险、IADL受限、活动受限、抑郁征象及居住情况等缺陷。
  • 根据评估结果指导治疗决策和干预,以减少生活质量下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Accumulation of geriatric deficits, leading to an increased frailty state, makes patients susceptible for decline in health-related quality of life (HRQOL) after treatment for head and neck cancer (HNC). OBJECTIVE: To assess the association of single and accumulated geriatric deficits with HRQOL decline in patients after treatment for HNC. DESIGN, SETTING, AND PARTICIPANTS: Between October 2014 and May 2016, patients at a tertiary referral center were included in the Oncological Life Study (OncoLifeS), a prospective data biobank, and followed up for 2 years. A consecutive series of 369 patients with HNC underwent geriatric assessment at baseline; a cohort of 283 patients remained eligible for analysis, and after 2 years, 189 patients remained in the study. Analysis was performed between March and November 2020. INTERVENTIONS OR EXPOSURES: Geriatric assessment included scoring of the Adult Comorbidity Evaluation 27, polypharmacy, Malnutrition Universal Screening Tool, Activities of Daily Living, Instrumental Activities of Daily Living (IADL), Timed Up & Go, Mini-Mental State Examination, 15-item Geriatric Depression Scale, marital status, and living situation. MAIN OUTCOMES AND MEASURES: The primary outcome measure was the Global Health Status/Quality of Life (GHS/QOL) scale of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Differences between patients were evaluated using linear mixed models at 3 months after treatment (main effects, β [95% CI]) and declining course per year during follow-up (interaction × time, β [95% CI]), adjusted for baseline GHS/QOL scores, and age, sex, stage, and treatment modality. RESULTS: Among the 283 patients eligible for analysis, the mean (SD) age was 68.3 (10.9) years, and 193 (68.2%) were male. Severe comorbidity (β = -7.00 [-12.43 to 1.56]), risk of malnutrition (β = -6.18 [-11.55 to -0.81]), and IADL restrictions (β = -10.48 [-16.39 to -4.57]) were associated with increased GHS/QOL decline at 3 months after treatment. Severe comorbidity (β = -4.90 [-9.70 to -0.10]), IADL restrictions (β = -5.36 [-10.50 to -0.22]), restricted mobility (β = -6.78 [-12.81 to -0.75]), signs of depression (β = -7.08 [-13.10 to -1.06]), and living with assistance or in a nursing home (β = -8.74 [-15.75 to -1.73]) were associated with further GHS/QOL decline during follow-up. Accumulation of domains with geriatric deficits was a major significant factor for GHS/QOL decline at 3 months after treatment (per deficient domain β = -3.17 [-5.04 to -1.30]) and deterioration during follow-up (per domain per year β = -2.74 [-4.28 to -1.20]). CONCLUSIONS AND RELEVANCE: In this prospective cohort study, geriatric deficits were significantly associated with HRQOL decline after treatment for HNC. Therefore, geriatric assessment may aid decision-making, indicate interventions, and reduce loss of HRQOL. TRIAL REGISTRATION: trialregister.nl Identifier: NL7839.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. de Vries J, Bras L, Sidorenkov G, et al. Association of Deficits Identified by Geriatric Assessment With Deterioration of Health-Related Quality of Life in Patients Treated for Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 34673914. doi:10.1001/jamaoto.2021.2837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。